PeerView | Oncology

Free CME from PeerView

Oncology CME

Credits: 1.0 CME / MOC / NCPD / CPE

Medical Learning Institute, Inc.

The Commanding Heights of MDS Care: Team Strategies for Delivering Modern Personalized Therapy

Guillermo Garcia-Manero, MD / Amy E. DeZern, MD, MHS

September 07, 2023

Credits: 1.0 CME / MOC / NCPD / CPE

Medical Learning Institute, Inc.

Setting New Expectations in Multiple Myeloma: Guidance on BCMA CAR-T & Antibody Options to Enhance Patient Care

Sagar Lonial, MD, FACP / Krina Patel, MD, MSc

September 07, 2023

Credits: 1.0 CME / MOC / NCPD / CPE

Medical Learning Institute, Inc.

Level Up With Personalized Care for CLL/SLL: Achieving Better Total Care With Targeted Agents & Innovative Combinations

William G. Wierda, MD, PhD / Nicole Lamanna, MD

September 07, 2023

Credits: 1.0 CME / MOC / NCPD / CPE

Medical Learning Institute, Inc.

Expanding the Circle of Personalized AML Treatment: Expert Consults on Integrating Precision Medicine With Innovative Treatment Platforms

Naval Daver, MD / Gail J. Roboz, MD

September 07, 2023

Credits: 1.0 CME

PVI, PeerView Institute for Medical Education

Can YOU Avoid Iatrogenic Harm? Understanding and Identifying Fibrodysplasia Ossificans Progressiva

Richard Keen, PhD, FRCP / Edna E. Mancilla, MD

August 31, 2023

Credits: 1.0 CME / MOC / NCPD / AAPA

PVI, PeerView Institute for Medical Education

Selective, Potent, Different: How to Enhance Clinical Benefits With Next-Generation ROS1 and TRK Inhibition in Treatment-Naïve and Pretreated NSCLC and Other Tumors

Alexander Drilon, MD

August 09, 2023

Credits: 1.0 CME / MOC / CC / NCPD / CPE / IPCE

PVI, PeerView Institute for Medical Education

Taking Direction From Biomarkers and Prognostic Factors in CLL: Interprofessional Strategies for Addressing Challenges With Continuous BTKi Therapy

Jennifer Woyach, MD

August 02, 2023

Credits: 0.5 CME / MOC / AAPA

PVI, PeerView Institute for Medical Education

Finding the Key to Better Outcomes in FLT3-Mutated AML: Guidance on New Evidence With Next-Gen FLT3 Inhibitors

Mark J. Levis, MD, PhD

August 02, 2023

Credits: 0.5 CME / MOC

PVI, PeerView Institute for Medical Education

A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC: The Latest Evidence and Practical Guidance for Biomarker Testing and Individualized Treatment Selection and Sequencing

Pasi A. Jänne, MD, PhD

July 20, 2023

Credits: 1.0 CME / MOC / AAPA / IPCE

PVI, PeerView Institute for Medical Education

The Team Takes Command in MDS: Guidance on Diagnostic and Treatment Principles for Risk-Based Care and Beyond

Guillermo Garcia-Manero, MD

July 04, 2023

Credits: 1.0 CME

PVI, PeerView Institute for Medical Education

Leading the Change in Hemophilia A: Guidance on Enhancing Prophylactic Care With Innovative EHL FVIII Products

Steven W. Pipe, MD / Maria Elisa Mancuso, MD, PhD

June 24, 2023

Credits: 0.75 CME

PVI, PeerView Institute for Medical Education

“Intensity” With Efficacy in Acute Myeloid Leukemia (AML): Developing Modern, Intensive Upfront Platforms for Challenging Disease Presentations

Prof. Thomas Cluzeau, MD, PhD

June 22, 2023

Credits: 1.5 CME

PVI, PeerView Institute for Medical Education

Taking the Leap in MCL: New Opportunities With BTK Inhibitors and Other Innovative Strategies

Prof. Dr. Martin Dreyling

June 19, 2023

Credits: 1.0 CME / MOC / CC / AAPA

PVI, PeerView Institute for Medical Education

Polishing Management Protocols in HER2-Expressing GI Cancers With Targeted Agents: A Focus on Refining Team-Based Strategies to Individualize BTC and GEA Care

Elena Elimova, MD, M.Sc., FRcPC

June 09, 2023

Credits: 1.5 CME / MOC / NCPD / AAPA

PVI, PeerView Institute for Medical Education

Progress on the Path to Improving Outcomes in the Treatment of SCLC: Making the Most of Current Standard-of-Care Therapies and Exploring New Promising Research

Taofeek K. Owonikoko, MD, PhD

June 05, 2023

Credits: 1.5 CME / MOC / AAPA

PVI, PeerView Institute for Medical Education

Amplifying the ADC Advantage: How to Fulfill the Potential of Antibody–Drug Conjugates as the Next Frontier in Precision Lung Cancer Care

Stephen V. Liu, MD

June 04, 2023

Credits: 1.0 CME / MOC / AAPA

PVI, PeerView Institute for Medical Education

Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms & Emerging Therapeutics

Ruben A. Mesa, MD, FACP

June 04, 2023

Credits: 1.5 CME / MOC / AAPA

PVI, PeerView Institute for Medical Education

Endometrial Cancer Care in the Age of Immunotherapy: Translating Clinical Evidence Into Meaningful Improvements in Patient Outcomes Across the Disease Continuum

David M. O'Malley, MD

June 04, 2023

Credits: 1.5 CME / MOC / NCPD / AAPA / IPCE

PVI, PeerView Institute for Medical Education

Immunotherapy for the Win Against Melanoma: Strategies for Integrating Innovative and Next-Generation Immunotherapy Options

Jason J. Luke, MD, FACP

June 04, 2023

Credits: 2.0 CME / MOC / AAPA

PVI, PeerView Institute for Medical Education

The New ABCs of Myeloma Care: Enhancing Outcomes With CD38 Antibodies, BCMA Immunotherapy, and Unique Bispecific Platforms

Robert Z. Orlowski, MD, PhD

June 04, 2023

Credits: 1.5 CME / MOC

PVI, PeerView Institute for Medical Education

Pushing Innovation in AML: Real-World Integration of Modern Therapeutics Into Personalized Patient Management

Naval Daver, MD

June 04, 2023

Credits: 1.5 CME / MOC / NCPD / AAPA

PVI, PeerView Institute for Medical Education

Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the Disease Spectrum

Sumanta Kumar Pal, MD, FASCO

June 03, 2023

Credits: 1.5 CME / MOC / NCPD / AAPA

PVI, PeerView Institute for Medical Education

Defying the Odds With Innovation in CLL: Perspectives on Personalized Care, Multiagent Platforms, and Sequential Strategies

Matthew S. Davids, MD, MMSc

June 03, 2023

Credits: 1.5 CME / MOC / AAPA / IPCE

PVI, PeerView Institute for Medical Education

Renovating the Clinical Rulebook for HCC: Multidirectional Management With Innovative Immunotherapy and Targeted Platforms

Ghassan Abou-Alfa, MD, MBA

June 03, 2023

Credits: 1.5 CME / MOC / AAPA

PVI, PeerView Institute for Medical Education

Building on the Immunotherapy Foundation for Head and Neck Cancer: Lessons Learned, Practical Guidance, and Next Steps in Care

Barbara Burtness, MD

June 02, 2023

Credits: 0.75 CME / MOC

PVI, PeerView Institute for Medical Education

Upgrading the Treatment Algorithm for Advanced Ovarian Cancer: Expert Tips, Tools, and Patient Care Strategies for Making the Most of PARP Inhibitors Across the Disease Continuum

Linda R. Duska, MD, MPH / Debra L. Richardson, MD, FACS, FACOG

May 16, 2023

Credits: 1.0 CME / MOC

PVI, PeerView Institute for Medical Education

Building a Foundation for Enhanced Outcomes in Pediatric ALL: Guidance on the Asparaginase Component of Modern Therapy

Luke Maese, DO / Rachel Rau, MD

May 11, 2023

Credits: 1.0 CME / MOC

PVI, PeerView Institute for Medical Education

The Bedrock of Personalized NF1 Care: Fundamentals of Managing NF1-Associated PNs and Other Tumors With Innovative Targeted Therapy

Laura Klesse, MD, PhD / Carlos G. Romo, MD

May 10, 2023

Credits: 1.0 CME

PVI, PeerView Institute for Medical Education

Bringing Precision Lung Cancer Care to the Perioperative Space: How to Maximize the Impact of EGFR-Targeted Therapy in Resectable NSCLC

Catherine Shu, MD / Brendon M. Stiles, MD

May 08, 2023

Credits: 1.0 CME / MOC

PVI, PeerView Institute for Medical Education

Neoadjuvant, Adjuvant, or Both: How to Solve the Puzzle of Perioperative Immunotherapy, Individualize Treatment Plans, and Improve Cure Rates in Resectable NSCLC

Jonathan D. Spicer, MD, PhD, FRCSC

May 06, 2023

Pages